Got $5,000? 2 Quantum Computing Stocks That Insiders Haven't Stopped Buying

IBM has deployed over 85 quantum systems running >3 trillion programs and aims for error-free quantum systems by 2029; analysts forecast 2025–2028 revenue and EPS CAGRs of ~5% and ~7%, and the stock trades at ~23x this year’s earnings while insiders bought ~60% as many shares as they sold in the past three months. IonQ projects growth from 64 physical qubits in 2025 to >2 million qubits by 2030, with analysts forecasting nearly 5x revenue growth from 2025–2028; it remains unprofitable and trades at ~26x 2028 sales, but insiders bought ~4x the shares they sold over the past three months. Both companies are presented as long-term, high-upside plays in quantum computing with differing risk profiles (IBM: slower-growth, cash-generative; IonQ: high growth, unprofitable).

Analysis

The headline bifurcation — IBM leveraging enterprise channels vs IonQ pursuing trapped‑ion miniaturization — primarily creates two second‑order markets: classical control/packaging (ASICs, photonics, fiber/optics, vacuum and laser subsystems) and cloud orchestration/software that stitches quantum jobs into enterprise AI workflows. If trapped‑ion approaches prove cheaper per logical qubit, it will shift capex away from cryogenics and dilution refrigerators into photonics and high‑channel‑count control ASICs, accelerating procurement for suppliers that aren’t on today’s radar but will matter to our hardware suppliers book within 12–36 months.

The path to commercial utility remains highly non‑linear. Error‑correction overheads imply physical→logical multipliers of 10^2–10^4, so “millions of physical qubits” may translate into far fewer logical qubits and a delayed revenue ramp unless control electronics and error rates improve in lockstep. That’s a binary execution risk for IonQ — a miss in either miniaturization or classical co‑processor scaling forces repeated dilutive raises. Conversely, IBM’s integration into hybrid cloud creates a smoother monetization runway but smaller upside; its optionality is de‑risked through enterprise lock‑ins rather than hardware breakthroughs.

Near term (quarters–2 years) catalysts are government contracts, a reported >100k physical‑qubit demonstrator, or a roadmap update on error correction; absence of those will keep volatility high. A contrarian read: current sentiment may underprice capital intensity and classical‑control bottlenecks, making pure hardware winners like IonQ binary and better expressed via asymmetric option structures rather than outright equity sizes.

Key Decisions for Investors

• Long IONQ via a funded LEAP call spread (buy 2028 LEAP calls, sell a higher‑strike 2028 call) sized 1–1.5% portfolio: asymmetric upside (3x–5x if roadmap milestones and a major government contract land) vs defined premium loss (~100% of allocation). Roll or reassess at each major milestone (public demo, 100k+ qubits, multi‑year cloud deal).
• Core overweight IBM at 3–5% portfolio weight on a 12–36 month horizon: buy into any >8–12% post‑earnings pullback or on confirmation of cross‑sell metrics tying quantum usage to hybrid‑cloud ARPU. Expect modest upside (20–35%); set stop/trim if hybrid cloud growth decelerates >200bps vs consensus.
• Small tactical short on INTEL via a 9–15 month put spread sized 0.5–1% portfolio: thesis is secular margin pressure + potential lost share if trapped‑ion displaces demand for superconducting‑focused fabs/control. Limited downside via spread; target 2x payoff if semiconductor capex skews away from Intel’s incumbency.
• Event trigger rule: add to IonQ position (up to +1% absolute) only upon two of three confirmations — published error‑rate reduction >10x, announcement of mass‑manufacturable photonic/laser ASIC partner, or a multi‑year government cloud contract. If none occur within 18 months, cut exposure entirely.